Krystal Biotech (KRYS) News Today $133.04 -4.03 (-2.94%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$133.05 +0.01 (+0.01%) As of 06/16/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KRYS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Is Abeona Therapeutics' Zevaskyn Worth $3.1m Per Treatment, Or Will Krystal Biotech Remain The Market Leader?June 16 at 6:28 AM | seekingalpha.comKrystal Biotech (NASDAQ:KRYS) & VectivBio (NASDAQ:VECT) Financial ComparisonJune 16 at 2:25 AM | americanbankingnews.comHandelsbanken Fonder AB Sells 11,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Handelsbanken Fonder AB cut its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 12.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 74,300 shares of the company's stock after selliJune 12, 2025 | marketbeat.comCantor Fitzgerald Predicts Krystal Biotech FY2026 EarningsJune 11, 2025 | americanbankingnews.comBrokers Offer Predictions for Krystal Biotech FY2026 EarningsKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Krystal Biotech in a report released on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings per shareJune 10, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Sells 3,473 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Hennion & Walsh Asset Management Inc. decreased its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 25.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,205 shares of the company's stock aftJune 6, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Purchased by GAMMA Investing LLCGAMMA Investing LLC boosted its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 50,249.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,342 shares of the company's stock aftJune 6, 2025 | marketbeat.comKrystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare ConferenceJune 3, 2025 | finance.yahoo.comImplied Volatility Surging for Krystal Biotech Stock OptionsJune 2, 2025 | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 23,197 Krystal Biotech, Inc. (NASDAQ:KRYS)Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 23,197 shares of the company's stock, valued at approximately $3,634June 2, 2025 | marketbeat.comSquarepoint Ops LLC Has $1.50 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Squarepoint Ops LLC reduced its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 29.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,559 shares of the company's stock after sellingJune 1, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by BrokeragesShares of Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) have earned an average rating of "Buy" from the nine research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, seven have issued a buy recommJune 1, 2025 | marketbeat.comKrystal Biotech Enters Oversold Territory (KRYS)May 31, 2025 | nasdaq.comKrystal Biotech (NASDAQ:KRYS) Hits New 12-Month Low - Here's WhyKrystal Biotech (NASDAQ:KRYS) Sets New 52-Week Low - Should You Sell?May 28, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 14,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 210,202 shares of the cMay 28, 2025 | marketbeat.comBank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Bank of America Corp DE cut its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 27.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 75,799 shares of the company's stock after sMay 25, 2025 | marketbeat.comPalisades Investment Partners LLC Purchases 3,436 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Palisades Investment Partners LLC boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,479 shares oMay 24, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Frazier Life Sciences Management L.P.'s 4th Largest PositionFrazier Life Sciences Management L.P. lessened its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 20.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 788,460 shares of the company's stocMay 23, 2025 | marketbeat.comWoodline Partners LP Buys 41,287 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Woodline Partners LP lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 23.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 221,102 shares of the company's stock after buying an additional 41,287 sharMay 23, 2025 | marketbeat.comNuveen Asset Management LLC Has $47.64 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Nuveen Asset Management LLC reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 304,115 shares of the company's stoMay 22, 2025 | marketbeat.comDeutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Deutsche Bank AG boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 62.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,361 shares of the company's stock after acquiring anMay 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial MarketsBNP Paribas Financial Markets lowered its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 25.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,789 shares of the company's stock after selling 2,644 shares during the period. BNP PMay 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Soleus Capital Management L.P.'s 5th Largest PositionSoleus Capital Management L.P. lifted its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 65.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 358,379 shares of the company's stock after buying an addiMay 21, 2025 | marketbeat.comRafferty Asset Management LLC Sells 18,639 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Rafferty Asset Management LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 40.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,201 shares of the company's stock after selling 18,639 shareMay 21, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 23,727 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Ameriprise Financial Inc. boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 26.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,476 shares of the companMay 19, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Reduced by Nicholas Investment Partners LPNicholas Investment Partners LP cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 73.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,086 shares of the company's stock after sellinMay 17, 2025 | marketbeat.comThe Analyst Verdict: Krystal Biotech In The Eyes Of 12 ExpertsMay 17, 2025 | benzinga.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn't IgnoreMay 14, 2025 | msn.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore (KRYS)These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and nextMay 14, 2025 | marketbeat.comIntegral Health Asset Management LLC Makes New $8.62 Million Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)Integral Health Asset Management LLC acquired a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 55,000 shares of thMay 14, 2025 | marketbeat.comKrystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For ConservativelyMay 13, 2025 | finance.yahoo.comFY2025 EPS Estimates for Krystal Biotech Lowered by AnalystKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at Chardan Capital cut their FY2025 earnings per share (EPS) estimates for Krystal Biotech in a note issued to investors on Wednesday, May 7th. Chardan Capital analyst Y. Livshits now expects that the company will earn $5.50 per share fMay 13, 2025 | marketbeat.comDriehaus Capital Management LLC Has $19.07 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Driehaus Capital Management LLC reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 25.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 121,702 shares of the company's stock after selling 41,602 shares during the period.May 11, 2025 | marketbeat.comNorthern Trust Corp Boosts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Northern Trust Corp grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 262,263 shares of the company's stock after acquiring an additional 23,572 sMay 11, 2025 | marketbeat.comHC Wainwright Forecasts Reduced Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at HC Wainwright dropped their Q2 2025 earnings per share estimates for Krystal Biotech in a research report issued on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earMay 10, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $5.52 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS)The Manufacturers Life Insurance Company grew its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 12.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,206 shares of the company's stock after purchasing an additionaMay 10, 2025 | marketbeat.comKrystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | insidermonkey.comKrystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | msn.comKrystal Biotech's (KRYS) Buy Rating Reiterated at Chardan CapitalChardan Capital reiterated a "buy" rating and set a $219.00 price target on shares of Krystal Biotech in a research report on Wednesday.May 9, 2025 | marketbeat.comKRYSTAL BIOTECH Earnings Results: $KRYS Reports Quarterly EarningsMay 8, 2025 | nasdaq.comKrystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $240.00 price objective on shares of Krystal Biotech in a research report on Tuesday.May 8, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Misses Expectations By $0.15 EPSKrystal Biotech (NASDAQ:KRYS - Get Free Report) issued its earnings results on Tuesday. The company reported $1.20 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.15). Krystal Biotech had a net margin of 30.69% and a return on equity of 11.41%.May 8, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Reaches New 12-Month Low Following Weak EarningsKrystal Biotech (NASDAQ:KRYS) Hits New 1-Year Low on Disappointing EarningsMay 8, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Boosted by Braidwell LPBraidwell LP grew its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 18.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 200,500 shares of the company's stock after buying an addMay 8, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by Hsbc Holdings PLCHsbc Holdings PLC grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 195.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,519 shares of the company's stock after bMay 8, 2025 | marketbeat.comKrystal Biotech First Quarter 2025 Earnings: Misses ExpectationsMay 7, 2025 | finance.yahoo.comKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call TranscriptMay 7, 2025 | msn.comKrystal Biotech to Present at BofA Securities 2025 Health Care ConferenceMay 7, 2025 | globenewswire.comKrystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...May 7, 2025 | finance.yahoo.comKrystal Biotech shares tumble as Q1 results miss expectationsMay 6, 2025 | investing.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼1.150.90▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼97▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GMAB News ITCI News RDY News MRNA News ASND News VTRS News QGEN News BPMC News ROIV News RVMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRYS Stock Free KRYS Stock Alerts